Category: Pharmaceuticals and Biotech
![Longevity Biotech Initiates Clinical Neuroinflammation Biomarker Study at the Department of Veterans Affairs to Investigate Immune Related Aspects of Parkinson's Disease With Continued Support From the Michael J. Fox Foundation](https://cdn.nwe.io/files/x/0c/18/91c354f437e598a963584bbba2aa.jpg)
Study aims to identify novel blood-based inflammatory markers that can be used to both identify and stratify Parkinson's disease patients
![Longevity Biotech Awarded $225K Phase I SBIR Contract From NHLBI/NIH to Develop 5A apoA-I Mimetic Peptide for Treatment of Severe Asthma](https://cdn.nwe.io/files/x/c6/be/93c64c2bd20bc381477554918901.jpg)
Broadens immunomodulatory peptide portfolio while also expanding route of administration capabilities
![Longevity Biotech Awarded Grant From National Multiple Sclerosis Society to Evaluate LBT-3627 as a Novel Drug Candidate for Multiple Sclerosis](https://cdn.nwe.io/files/x/cc/9d/ce17d9c01fb50fefb70ba532ab4e.jpg)
Launches preclinical development effort of LBT-3627 as a neuroprotective/repair treatment for Multiple Sclerosis